Michael S. Okun

From Wikipedia, the free encyclopedia
Michael S. Okun
Born (1971-07-05) July 5, 1971 (age 52)
Academic background
EducationFlorida State University (B.S.)

University of Florida (M.D., Residency)

Emory University (Fellowship)[1]
Academic work
InstitutionsUniversity of Florida

Michael S. Okun (born July 5, 1971) is an American neurologist, neuroscientist and author. He is the co-founder and director of the Norman Fixel Institute for Neurological Diseases at University of Florida Health[2] and is also the chair of the Department of Neurology at the University of Florida and the Medical Director/Advisor for the Parkinson's Foundation.[2] He is the fifth person at the University's College of Medicine to hold the rank of Distinguished Professor.[3]

Career[edit]

Tourette syndrome[edit]

Okun opened his laboratory in 2002 at the McKnight Brain Institute on the University of Florida Campus. The laboratory focused on uncovering the underpinnings of human tic in Tourette syndrome, exploring non-motor basal ganglia circuitry in Parkinson’s disease, Tourette, dystonia, OCD and tremor and the aim of the laboratory was to innovate neuromodulation and circuit-based treatments for multiple neurological and neuropsychiatric diseases. [4]

Okun recognized that some diseases lacked animal models which would recapitulate the human condition(s). He advocated and implemented a neuroethics-based approach to utilize the operating room and the outpatient clinic setting for research into these neurological conditions. The Okun laboratory originally focused on Tourette syndrome because of the paroxysmal nature of human tic, which made it ideal to explore the physiological underpinnings of the movement disorder.[5] His work has been important in understanding the biological changes underpinning the neural network changes which underpin the symptomatic benefits of deep brain stimulation and for moving toward symptom and circuit based treatments rather than disease based treatments. Okun has trained over 70 clinical MD fellows and many researchers in basal ganglia and related disorders.[6]

Okun, Foote and Gunduz were featured on an episode of Vital Signs with CNN's Sanjay Gupta, who scrubbed in to the operating room with the team and explored their approach to innovating new therapies for Tourette syndrome.[7]

Okun and the University of Florida based group performed a series of National Institutes of Health, foundation and philanthropically funded experiments between 2002 and 2022 that resulted in the successful characterization of human tic physiology.[citation needed]

Parkinson’s Disease Deep Brain Stimulation[edit]

Okun designed and carried out one of the first large prospective randomized Parkinson’s disease trials comparing the two most common DBS brain targets. The study, known as the NIH COMPARE trial, revealed unilateral STN or GPi DBS resulted in similar motor benefits, however there were important advantages and disadvantages for using each brain target.[8]

Awards[edit]

Okun has been recognized as the top clinical-researcher at the University of Florida College of Medicine (2021) and he was also recognized in a 2015 White House ceremony by the Obama administration as a Champion of Change for Parkinson's Disease.[9]

Writings[edit]

Okun's first book as an author was Lessons from the Bedside which this was published in 1995 as a book of prose and poetry which chronicled the medical school experience. He was interviewed for the PBS series Healing Words (2008) which focused on poetry in medicine.

Okun has been published in the New England Journal of Medicine, Lancet, and the Journal of the American Medical Association.[10] He has authored or co-authored 14 books[citation needed] and hundreds of research articles.[11]

Selected publications[edit]

  • Okun, Michael S. (2013). Parkinson's treatment : the 10 secrets to a happier life (English ed.). [United States]: [CreateSpace]. ISBN 978-1-4818-5499-3. OCLC 842155662[12][13] was translated into over 20 languages and it was the first to propose the idea of a coming "Parkinson's pandemic."
  • Dorsey, Ray (2020). Ending Parkinson's disease : a prescription for action. Todd Sherer, Michael S. Okun, Bastiaan R. Bloem (First ed.). New York. ISBN 978-1-5417-2452-5. OCLC 1108524282. which was co-authored by Ray Dorsey, Todd Scherer and Bastiaan Bloem, Okun introduced the idea of a PACT to end Parkinson's disease (Prevent, Advocate, Care, develop Treatments).[14]
  • Pringsheim T, Holler-Managan Y, Okun MS, et al. (May 2019). "Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders". Neurology (Review). 92 (19): 907–915. doi:10.1212/WNL.0000000000007467. PMC 6537130. PMID 31061209.

References[edit]

  1. ^ "National Medical Advisor | Parkinson's Foundation". www.parkinson.org. Parkinson's Foundation. Retrieved 17 November 2023.
  2. ^ a b Lang, Katharine (11 Jan 2024). "Parkinson's disease: Could a novel molecular test speed up diagnosis?". Medical and health information. Retrieved 28 Jan 2024.
  3. ^ "Michael Okun". IHMC | Institute for Human & Machine Cognition. Retrieved 16 February 2024.
  4. ^ "Michael S Okun » Department of Neurology » College of Medicine » University of Florida". University of Florida.
  5. ^ "Dr. Michael Okun, MD, honored by American Society for Experimental Neurotherapeutics! » Department of Neurology » College of Medicine »". University of Florida.
  6. ^ "MRI Technique May Help Detect Parkinson's Earlier". HealthDay. 12 June 2014.
  7. ^ Gupta, Sanjay (27 June 2015). "Vital Signs with Dr. Sanjay Gupta". transcripts.cnn.com. CNN. Retrieved 3 March 2024.
  8. ^ Okun, Michael S.; Fernandez, Hubert H.; Wu, Samuel S.; Kirsch-Darrow, Lindsey; Bowers, Dawn; Bova, Frank; Suelter, Michele; Jacobson, Charles E.; Wang, Xinping; Gordon, Clifford W.; Zeilman, Pam; Romrell, Janet; Martin, Pam; Ward, Herbert; Rodriguez, Ramon L.; Foote, Kelly D. (May 2009). "Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial". Annals of Neurology. 65 (5): 586–595. doi:10.1002/ana.21596. ISSN 1531-8249. PMC 2692580. Retrieved 28 April 2024.
  9. ^ "How to Make a Difference in Parkinson's Disease Patients' Lives Today and Every Day". The White House. 30 March 2015.
  10. ^ Bloem BR, Okun MS, Klein C (June 2021). "Parkinson's disease" (PDF). Lancet. 397 (10291): 2284–2303. doi:10.1016/S0140-6736(21)00218-X. PMID 33848468.
  11. ^ "Toxicology and Societies Speaker Series". Western Washington University. 11 Mar 2021. Retrieved 13 Jan 2024.
  12. ^ Michael_Okun; r/Science (4 November 2017). "Science AMA Series: I'm Michael S. Okun, M.D., chair of the University of Florida department of neurology and medical director of the Parkinson's Foundation. I wrote a book "Parkinson's Treatment: 10 Secrets to a Happier Life" AMA!". The Winnower. doi:10.15200/winn.150970.09877.
  13. ^ Michael_Okun; r/Science. "Science AMA Series: I'm Michael S. Okun, M.D., chair of the University of Florida department of neurology and medical director of the Parkinson's Foundation. I wrote a book "Parkinson's Treatment: 10 Secrets to a Happier Life" AMA!". doi:10.15200/winn.150970.09877. {{cite journal}}: Cite journal requires |journal= (help)
  14. ^ Hu, Michele T. (2020-04-03). "Book Review of "Ending Parkinson's Disease: A Prescription for Action"". Journal of Parkinson's Disease. 10 (2): 743–744. doi:10.3233/jpd-200003. ISSN 1877-7171. S2CID 214810804.

Further reading[edit]